Viridian Therapeutics (VRDN) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free VRDN Stock Alerts $13.91 -0.99 (-6.64%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalyst Issues Buy Rating for Viridian Therapeutics Amid Positive Clinical Progress and Strategic BLA Submission Planmarkets.businessinsider.com - May 10 at 8:28 AMBuy Rating Affirmed for Viridian Therapeutics Amidst Accelerated Clinical Progress and Market Expansion Potentialmarkets.businessinsider.com - May 10 at 8:28 AMViridian Therapeutics to Participate in Upcoming May Investor Conferencesbusinesswire.com - May 10 at 8:00 AMViridian Therapeutics, Inc. Expected to Post Q2 2024 Earnings of ($0.90) Per Share (NASDAQ:VRDN)marketbeat.com - May 10 at 6:35 AMLadenburg Thalmann Downgrades Viridian Therapeutics (VRDN)msn.com - May 10 at 3:28 AMViridian Therapeutics (NASDAQ:VRDN) Shares Gap Down Following Analyst Downgradeamericanbankingnews.com - May 10 at 2:04 AMBuy Rating Affirmed for Viridian Therapeutics on Strong Clinical Trials and Promising Drug Prospectsmarkets.businessinsider.com - May 9 at 10:27 PMViridian Therapeutics (NASDAQ:VRDN) Given New $27.00 Price Target at HC Wainwrightmarketbeat.com - May 9 at 4:46 PMViridian Therapeutics (NASDAQ:VRDN) Shares Gap Down on Analyst Downgrademarketbeat.com - May 9 at 2:02 PMViridian Therapeutics (NASDAQ:VRDN) Posts Quarterly Earnings Results, Beats Estimates By $0.28 EPSmarketbeat.com - May 9 at 12:58 PMViridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2024 Earnings Call Transcriptmsn.com - May 9 at 12:26 PMViridian Therapeutics (NASDAQ:VRDN) Stock Rating Lowered by LADENBURG THALM/SH SHmarketbeat.com - May 9 at 8:51 AMViridian Therapeutics (NASDAQ:VRDN) Rating Reiterated by Needham & Company LLCmarketbeat.com - May 9 at 8:51 AMViridian Therapeutics Inc (VRDN) Q1 2024 Earnings Call Transcript Highlights: Strategic ...finance.yahoo.com - May 9 at 7:25 AMViridian Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - May 9 at 7:25 AMBuy Rating Affirmed for Viridian Therapeutics Amidst Strong Pipeline Progress and Solid Financial Standingmarkets.businessinsider.com - May 8 at 9:22 PMBuy Rating Affirmed for Viridian Therapeutics on Promising VRDN-001 Trials and Strong Financial Outlookmarkets.businessinsider.com - May 8 at 9:22 PMViridian Therapeutics Inc (VRDN) Q1 2024 Earnings: Narrowing Losses Amidst Clinical Advancementsfinance.yahoo.com - May 8 at 9:22 PMVRDN Stock Earnings: Viridian Therapeutics Beats EPS, Beats Revenue for Q1 2024investorplace.com - May 8 at 1:15 PMViridian Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - May 8 at 12:03 PMViridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Resultsbusinesswire.com - May 8 at 7:00 AMPacific Urban Investors Expands Denver Portfolio with Acquisition of Viridian Apartment Community in Greenwood Villageglobenewswire.com - May 7 at 7:33 PMViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - May 3 at 8:00 AMViridian Therapeutics (VRDN) Set to Announce Quarterly Earnings on Wednesdaymarketbeat.com - May 1 at 9:19 AMViridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024businesswire.com - April 29 at 8:00 AMViridian Therapeutics (NASDAQ:VRDN) Stock Price Down 6.2%marketbeat.com - April 24 at 6:51 PMKnights of Columbus Asset Advisors LLC Boosts Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN)marketbeat.com - April 21 at 6:39 AMViridian Therapeutics (NASDAQ:VRDN) Sees Unusually-High Trading Volumemarketbeat.com - April 19 at 11:58 AMViridian Therapeutics (NASDAQ: VRDN)fool.com - April 13 at 3:28 PMViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by Vanguard Group Inc.marketbeat.com - April 11 at 4:11 AMViridian Therapeutics (NASDAQ:VRDN) Trading Down 7.5%marketbeat.com - April 10 at 2:51 PMBuy Rating Affirmed for Viridian Therapeutics Amidst TED Treatment Market Potentialmarkets.businessinsider.com - April 6 at 2:51 AMViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - April 4 at 4:01 PMViridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Rating of "Buy" from Brokeragesmarketbeat.com - April 4 at 2:16 AMViridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by SG Americas Securities LLCmarketbeat.com - April 1 at 4:23 AMVIRIDIAN SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Viridian Therapeutics, Inc. (VRDN) and Encourages Investors to Contact the Firmprnewswire.com - March 29 at 9:00 AMAnalysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)markets.businessinsider.com - March 25 at 10:01 PMViridian Therapeutics (NASDAQ:VRDN) Stock Price Down 4.7% Following Analyst Downgrademarketbeat.com - March 22 at 12:27 PMB. Riley Cuts Viridian Therapeutics (NASDAQ:VRDN) Price Target to $25.00marketbeat.com - March 21 at 10:55 AMBuy Rating Endorsed for Viridian Therapeutics’ VRDN Treatments Based on Superior Efficacy and Dosing Advantages in TED Marketmarkets.businessinsider.com - March 20 at 8:21 PMUnveiling 4 Analyst Insights On Viridian Therapeuticsmarkets.businessinsider.com - March 20 at 3:20 PMViridian Therapeutics (NASDAQ:VRDN) Given Buy Rating at Needham & Company LLCmarketbeat.com - March 20 at 1:44 PMFinding the Next Big Winners: 3 Stocks You Can Snag for Under $20investorplace.com - March 19 at 6:51 PMVRDN Sep 2024 20.000 putfinance.yahoo.com - March 16 at 8:46 AMVRDN Apr 2024 20.000 putfinance.yahoo.com - March 16 at 8:46 AMSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Viridian Therapeutics, Inc. (VRDN) and Encourages Investors to Contact the Firmstockhouse.com - March 15 at 11:23 PMViridian Therapeutics (NASDAQ:VRDN) Shares Down 8.4% marketbeat.com - March 12 at 1:24 PMVRDN Makes Bullish Cross Above Critical Moving Averagenasdaq.com - March 9 at 2:40 PMSchonfeld Strategic Advisors LLC Grows Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)marketbeat.com - March 9 at 5:42 AMViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - March 6 at 4:01 PM Get Viridian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address READ THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.” Click on Adam's shiny forehead for more details. VRDN Media Mentions By Week VRDN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRDN News Sentiment▼0.150.45▲Average Medical News Sentiment VRDN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRDN Articles This Week▼253▲VRDN Articles Average Week Get Viridian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FLGT News Today CSTL News Today CELC News Today CDNA News Today SERA News Today VCYT News Today PMD News Today GH News Today ARWR News Today FTRE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRDN) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
